Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionSteadtrust LLC
Latest Disclosed Ownership36,100 shares
Latest Disclosed Value $ 1,087,332
Steadtrust LLC reports 3.22% decrease in ownership of TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On April 15, 2026 - Steadtrust LLC filed a 13F-HR form disclosing ownership of 36,100 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $1,087,332 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 37,300 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of -3.22% during the quarter. The current value of the position is $1,242,923 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 36,100 -1,200 -3.22 1,087 -6.62 0.6166
2026-01-21 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 37,300 0 0.00 1,164 54.58 0.7166
2026-01-21 2025-09-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 37,300 13,700 58.05 753 90.63 0.5102
2025-12-02 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 37,300 13,700 753 0.5102
2026-01-21 2025-06-30 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 23,600 23,600 396 0.3108
2025-12-01 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 23,600 23,600 396 0.3108
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.